Iraola praises Liverpool substitutes while Jaissle hails Newcastle’s ‘heart’ after dramatic stalemateAugust 23, 2026
Jared Kushner meets with Democratic leader Jeffries with House control at stake in NovemberAugust 23, 2026
Abcuro Adds $66M to Try Again in Rare Inflammatory Disorder With No Approved DrugsNews DeskAugust 23, 20260 Immunotherapy developer Abcuro received disappointing news this year as its lead drug candidate fell short in a clinical trial expected…
Braveheart Bio’s $382M IPO for Heart Drug Leads a Big Week for Biotech IPOsNews DeskAugust 10, 20260 One takeaway from this year’s surge of biotech IPO activity is that investors want to see at least some clinical…
Latigo Bio’s IPO Lands $346M for Pipeline of Non-Opioid Pain DrugsNews DeskAugust 9, 20260 The race for non-opioid pain drugs continues, and Latigo Biotherapeutics is building the case for a molecule it says could…